Home

The Center for Beta Cell Therapy in Diabetes develops and implements methods that restore an adequate mass of insulin-producing beta cells in patients with diabetes.

It organizes and coordinates a Research & Development Platform that drives Clinical Trials. Its R&D program is undertaken by an international consortium with partners from research institutions, university hospitals and bio-industry. Translation to clinical and bio-industrial application is guided by a common roadmap towards the Center objectives. Clinical studies and implementation are conducted in a clinical trial network aiming prevention and treatment of type 1 diabetes.

Since its inception in 2002, the Center has received support for its program from the European Union (FP6 and FP7) and the Juvenile Diabetes Research Foundation (JDRF).